Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Kuros Biosciences to present at upcoming U.S. spine conferences
Kuros Biosciences’s commercial roll-out of MagnetOs bone graft exceeds expectations
Kuros to receive $4 million milestone payment from Checkmate Pharmaceuticals
Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion
Annual General Meeting of Kuros Biosciences approves majority of resolutions
Kuros Biosciences treats first patient in clinical trial of MagnetOs Putty for posterolateral spine fusion